Sort
50,496 grants matching “lung cancer”
Role of tumor cell cluster-induced signaling in breast cancer metastasis
$402,600Kevin Jon Cheung · Fred Hutchinson Cancer Center · R37 · FY2025 · CA
Interrogation of MLL2 as a tumor suppressor gene in lung cancer
$402,600David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance
$402,600Cyrus M Ghajar · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Role of tumor cell cluster-induced signaling in breast cancer metastasis
$402,600Kevin Jon Cheung · Fred Hutchinson Cancer Research Center · R37 · FY2021 · CA
Interrogation of MLL2 as a tumor suppressor gene in lung cancer
$402,600David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Understanding the RhoGDI2 metastasis suppressor gene
$402,559Dan Theodorescu · University Of Colorado Denver · R01 · FY2010 · CA
Erythropoietin Blockade for the Treatment of Cancer
$402,553C. Anthony Blau · University Of Washington · R01 · FY2012 · CA
AMPK and AMPK-related kinases in lung cancer development and treatment
$402,550Reuben J Shaw · Salk Institute For Biological Studies · R01 · FY2013 · CA
AMPK and AMPK-related kinases in lung cancer development and treatment
$402,550Reuben J Shaw · Salk Institute For Biological Studies · R01 · FY2016 · CA
AMPK and AMPK-related kinases in lung cancer development and treatment
$402,550Reuben J Shaw · Salk Institute For Biological Studies · R01 · FY2015 · CA
AMPK and AMPK-related kinases in lung cancer development and treatment
$402,550Reuben J Shaw · Salk Institute For Biological Studies · R01 · FY2017 · CA
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$402,548Andrea Facciabene · University Of Pennsylvania · R01 · FY2017 · CA
The role of Bik in the replication and severity of influenza A virus
$402,475Yohannes Afework Mebratu · Ohio State University · R01 · FY2023 · AI
Clinical Trials Office
$402,446Scott A Baker · University Of Minnesota · P30 · FY2009 · CA
In situ radioimmunotherapy to maximize the engagement of conventional type 1 dendritic cells against non-T cell-inflamed tumors
$402,417Fumito Ito · University Of Southern California · R01 · FY2022 · CA
Metabolic control of DNA repair in pulmonary fibrosis
$402,414Ross S Summer · Thomas Jefferson University · R01 · FY2017 · HL
Antitumor potential of AvFc lectibody in non-small cell lung cancer
$402,402Nobuyuki Matoba · University Of Louisville · R21 · FY2023 · CA
Evaluating the role of SPAK and OSR1 kinases in glioblastoma chemotherapy resistance
$402,401Paula V Schiapparelli · Mayo Clinic Jacksonville · R21 · FY2024 · CA
A lung cancer vaccine based on exosomes of induced pluripotent stem cells
$402,401Chi Li · University Of Louisville · R21 · FY2023 · CA
Evaluating a Novel Autophagy Inhibitor in KRAS-Driven Lung Cancer
$402,401Jeffrey Paul Mackeigan · Michigan State University · R21 · FY2021 · CA
Regulation of collagen linearization during cancer progression and metastasis
$402,394Myriam Labelle · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Regulation of collagen linearization during cancer progression and metastasis
$402,394Myriam Labelle · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
HuR Targeted Nanotherapy for Lung Cancer
$402,385Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2013 · CA
ENDOBRONCHIAL PHOTOACOUSTIC MICROSCOPY FOR STAGING OF LUNG CANCER
$402,378University Of Florida · · FY2014 · Department of the Army
Efficacy-to-Effectiveness Transition of an Educational Program to Increase Colore
$402,371Joseph Hobbs · Augusta University · R01 · FY2016 · CA